United Kingdom · How much has PharmEnable Therapeutics raised?
PharmEnable Therapeutics has raised $7.5M across 3 rounds since 2022.
2023
$5.2MSeries A$257KSeries A$2.1MSeries A
United Kingdom · Series A startup
Who invested in PharmEnable Therapeutics
3 rounds we have observed, with the 0 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow PharmEnable Therapeutics and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$7.5Mraised across 3 rounds since 2022, from 3 sources
$5.2MSeries A$257KSeries A$2.1MSeries A
- Latest round
- Series A, $2.1MDec 2023
- Biggest round
- $5.2MSeries A · Nov 2022
- Step-upi
- 8.1×
- Investors
- 0
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $5.2M Nov 2022
- Biggest round
- $5.2M Series A · Nov 2022
- Usual gap between rounds
- 8 months the median of 2
The rounds
- Dec 2023Series A$2.1M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
- Jul 2023Series A$257K
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
- Nov 2022Series A$5.2M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Funding filed with regulators
PharmEnable Therapeutics filed 4 raises, $7.5M in all. Filings say how much was sold and to how many investors; they never name the investors.
- Dec 2023$2.1MUK share allotment
- Jul 2023$257KUK share allotment
- Nov 2022$1.4MUK share allotment
- Nov 2022$3.8MUK share allotment
Quick answers about PharmEnable Therapeutics
When did PharmEnable Therapeutics last raise?
PharmEnable Therapeutics's most recent round was a Series A of $2.1M in Dec 2023.
What was PharmEnable Therapeutics's biggest round?
PharmEnable Therapeutics's largest round on record is $5.2M (Series A), in Nov 2022.
What stage is PharmEnable Therapeutics at?
PharmEnable Therapeutics's latest named round is a Series A, in Dec 2023.
Where is PharmEnable Therapeutics based?
PharmEnable Therapeutics is based in the United Kingdom.
Companies like PharmEnable Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.